NCT02832570View on ClinicalTrials.gov

Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 7, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions

Peripheral Arterial Occlusive Disease

Interventions

DRUG

Sildenafil 100mg single oral dose

Measurement of maximal walking distance on a constant load treadmill test (3.12 km/ 10% slope)

DRUG

Placebo, Oral intake single dose

Measurement of maximal walking distance on a constant load treadmill test (3.12 km/ 10% slope)

All Listed Sponsors

lead

University Hospital, Angers

OTHER_GOV

NCT02832570 - Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication | Biotech Hunter | Biotech Hunter